Hemorrhoid Treatment Devices Market

• In February 2022, a clinical trial by the State Scientific Centre of Coloproctology, Russian Federation, was conducted on treating hemorrhoids with a 1940nm laser procedure. These clinical trials will increase the product pipeline in the future.

• In January 2022, Cook Medical launched a medical device manufacturing facility in Indianapolis. The USD 15 million, 40,000 sq. foot facility will begin production in the first quarter of 2022.

In this report, the Hemorrhoid Treatment Devices Market has been segmented by device type, procedure, end user and geography.

Hemorrhoid Treatment Devices Market, Segmentation by Device Type

The Hemorrhoid Treatment Devices Market has been segmented by Device Type into Rubber Band Ligators, Infrared Coagulators, Proctoscopes, Anoscopes, Doppler Probes, Cryotherapy Devices, Bipolar Probes and Others.

Rubber Band Ligators

Rubber band ligation is one of the most widely used minimally invasive hemorrhoid treatments, accounting for approximately 35-40% of outpatient procedures. The device works by placing a tight rubber band around the base of hemorrhoids, cutting off blood supply and allowing them to fall off naturally. This procedure is especially effective for internal hemorrhoids and provides a success rate of over 90% in symptom relief, making it a preferred choice in many clinics.

Infrared Coagulators

Infrared coagulation devices use targeted infrared light to shrink hemorrhoidal tissue and coagulate blood vessels. Representing around 20-25% of non-surgical treatments, this technique is appreciated for its pain-free and rapid procedure. Infrared coagulation is ideal for grade I and II hemorrhoids and is known for low recurrence rates, which enhances patient satisfaction and treatment outcomes.

Proctoscopes

Proctoscopes are crucial for both diagnosis and treatment of hemorrhoids, involved in nearly 15% of procedures. These devices allow clinicians to visualize internal hemorrhoids accurately before interventions. Improved instrument design enhances precision during surgical procedures and aids in early detection, which contributes to better treatment success rates.

Anoscopes

Anoscopes provide clear visualization of the anal canal and are used in approximately 10-12% of hemorrhoid treatments. They are particularly valuable in outpatient and minimally invasive procedures. Their straightforward design allows accurate medication application and minor interventions, significantly reducing procedural complications and enhancing patient comfort.

Doppler Probes

Doppler-guided hemorrhoid devices detect arterial blood flow using ultrasound technology, ensuring precise ligation of hemorrhoid arteries. These devices are utilized in about 8-10% of advanced treatments and help minimize postoperative pain while reducing recurrence rates. Doppler probes are a key tool in modern, technology-driven hemorrhoid treatment protocols.

Cryotherapy Devices

Cryotherapy devices treat hemorrhoids by freezing affected tissue to reduce inflammation and shrink veins. Adoption remains limited to 5-7% of procedures due to specialized equipment requirements, but cryotherapy offers a non-invasive alternative for patients avoiding surgery. It is particularly suitable for sensitive cases, focusing on quick recovery and reduced discomfort.

Bipolar Probes

Bipolar probes use electrocoagulation to precisely target hemorrhoidal tissue with controlled electrical energy. These devices account for 3-5% of interventions, mostly in hospital settings for complex cases. Bipolar technology ensures minimal bleeding and faster healing, making it increasingly popular for severe hemorrhoids treatment.

Others

The Others category includes emerging technologies such as laser therapy units and hybrid devices, representing about 2-3% of the market. These innovative tools are gradually gaining adoption in specialized clinics due to their advanced features and patient-friendly design. They reflect the ongoing evolution of hemorrhoid treatment technologies.

Hemorrhoid Treatment Devices Market, Segmentation by Procedure

The Hemorrhoid Treatment Devices Market has been segmented by Procedure into Rubber Band Ligation, Sclerotherapy, Infrared Coagulation and Others.

Rubber Band Ligation

Rubber band ligation is a widely used minimally invasive procedure for treating internal hemorrhoids. It accounts for approximately 40-45% of all hemorrhoid procedures due to its high success rate and quick recovery. The technique involves placing a tight rubber band around the hemorrhoid base, cutting off blood flow and causing it to fall off naturally. This method is highly effective for grades I and II hemorrhoids and preferred in outpatient settings.

Sclerotherapy

Sclerotherapy is a non-surgical procedure that uses chemical solutions to shrink hemorrhoids by causing fibrosis in the veins. It accounts for about 20-25% of treatment procedures and is especially suitable for small to medium-sized hemorrhoids. The procedure is quick, minimally painful, and offers a short recovery period, making it a popular choice for patients seeking office-based treatments.

Infrared Coagulation

Infrared coagulation employs infrared light to coagulate blood vessels and reduce hemorrhoidal tissue size. Representing roughly 15-20% of procedures, it is favored for its fast, outpatient-friendly approach. Infrared coagulation is particularly effective for grade I and II internal hemorrhoids and is associated with low recurrence rates and minimal discomfort, improving patient satisfaction.

Others

The Others category includes emerging treatments such as laser therapy and combination procedures, accounting for around 5-10% of procedures. These methods are still being adopted in specialized clinics due to high equipment costs but offer innovative, patient-friendly solutions. They reflect ongoing advancements in hemorrhoid treatment technology and provide alternatives for complex or recurrent cases.

Hemorrhoid Treatment Devices Market, Segmentation by End User

The Hemorrhoid Treatment Devices Market has been segmented by End User into Hospitals And Clinics , Ambulatory Surgery Centers and Others.

Hospitals and Clinics

Hospitals and clinics represent the largest end user segment in the hemorrhoid treatment devices market, accounting for nearly 60-65% of the market. These settings utilize a wide range of advanced hemorrhoid treatment devices due to their access to specialized equipment and skilled professionals. Hospitals and clinics are preferred for complex cases and provide comprehensive care, including minimally invasive and surgical procedures, ensuring high patient success rates.

Ambulatory Surgery Centers

Ambulatory surgery centers (ASCs) account for around 25-30% of the end-user market, offering outpatient hemorrhoid treatments with a focus on efficiency and patient convenience. ASCs are ideal for minimally invasive procedures like rubber band ligation and infrared coagulation. They provide shorter recovery times and lower costs compared to hospitals, making them increasingly popular for day-care hemorrhoid interventions.

Others

The Others segment, representing about 5-10% of the market, includes specialized clinics, diagnostic centers, and emerging healthcare facilities. These end users adopt innovative hemorrhoid treatment technologies and cater to niche patient groups. Although smaller in market share, they contribute to technology adoption and patient-focused solutions, reflecting the growing diversification of healthcare delivery for hemorrhoid treatments.

Hemorrhoid Treatment Devices Market, Segmentation by Geography

In this report, the Hemorrhoid Treatment Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Hemorrhoid Treatment Devices Market Share (%), by Geographical Region

North America

North America holds the largest share in the hemorrhoid treatment devices market, accounting for nearly 35-40% of global revenue. The region benefits from advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong presence of leading device manufacturers. Patient awareness and insurance coverage contribute to the widespread use of innovative hemorrhoid treatments in hospitals and clinics across the US and Canada.

Europe

Europe represents around 25-30% of the market, driven by well-established healthcare systems and increasing demand for outpatient hemorrhoid treatments. Countries such as Germany, the UK, and France have seen significant adoption of rubber band ligation, sclerotherapy, and infrared coagulation. Regulatory support and technological advancements are further boosting market growth across the region.

Asia Pacific

Asia Pacific is emerging as a fast-growing market, contributing approximately 20-25% of global sales. The growth is fueled by rising healthcare infrastructure, medical tourism, and increasing awareness of minimally invasive treatments. Countries like China, India, and Japan are witnessing higher adoption rates for advanced hemorrhoid devices in both hospitals and outpatient clinics.

Middle East and Africa

The Middle East and Africa account for about 5-8% of the market, with growth driven by urbanization, healthcare investments, and awareness campaigns. Countries like Saudi Arabia, UAE, and South Africa are seeing increased demand for modern hemorrhoid treatment devices in private hospitals and specialty clinics. Limited access in rural areas is gradually improving with healthcare expansion initiatives.

Latin America

Latin America represents around 5-7% of the market, with Brazil and Mexico leading regional adoption. The growth is supported by rising healthcare spending, increased patient awareness, and the availability of minimally invasive hemorrhoid treatments in urban centers. The market is expected to expand further as access to advanced medical devices continues to improve.

This report provides an in depth analysis of various factors that impact the dynamics of Global Hemorrhoid Treatment Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Key players in Global Hemorrhoid Treatment Devices Market include:

• Cook Medical
• Medtronic Plc
• Privi Medical
• Integra Lifesciences Corporation
• Sklar Surgical Instruments
• Obp Medical Corporation
• Conmed Corporation
• Boston Scientific Corporation
• Johnson & Johnson Services.

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis